Literature DB >> 17694292

Accumulation of dietary glycotoxins in the reproductive system of normal female rats.

Evanthia Diamanti-Kandarakis1, Christina Piperi, Penelope Korkolopoulou, Eleni Kandaraki, Georgia Levidou, Apostolos Papalois, Efstratios Patsouris, Athanasios G Papavassiliou.   

Abstract

The aim of the present study was to investigate whether dietary advanced glycation end-products (AGEs) can be detected in the ovarian tissue of normal female rats and whether they can affect their metabolic or hormonal profile. Sixty normal rats (20 animals in each group) were randomly assigned to regular diet, either high (H-AGE) or low (L-AGE) in AGE content for 6 months. H-AGE rats demonstrated higher levels of fasting glucose (P < 0.001), insulin (P < 0.069), and serum AGEs (P < 0.001) than control and L-AGE rats. Additionally, the H-AGE group showed increased AGE localization in the theca interna cells of the ovarian tissue compared to control/L-AGE rats (P = 0.003). Furthermore, increased receptor for AGE (RAGE) staining was also observed in granulosa cells compared to control/L-AGE samples (P = 0.038). In the H-AGE group, plasma testosterone was higher than in control rats (P < 0.001) and in the L-AGE group (P < 0.001). However, H-AGE rats did not exhibit higher body weight compared with normal (P = 0.118) and L-AGE-fed rats (P = 0.35). These results demonstrate for the first time that administration of high AGE diet in female rats for a prolonged period is associated with increased deposition of AGEs in the theca cells and of RAGE in the granulosa and theca interna cells of the ovarian tissue compared with the corresponding ovarian compartments of the control and L-AGE-fed animals. The metabolic alterations in conjuction with the increased deposition in ovarian tissues of dietary glycotoxins and elevated levels of testosterone in H-AGE-fed animals compared to the controls suggest an impact of environmental factors on ovarian tissue and these findings need further exploration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694292     DOI: 10.1007/s00109-007-0246-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  20 in total

Review 1.  The Maillard hypothesis on aging: time to focus on DNA.

Authors:  John W Baynes
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

Review 2.  Nutritional and toxicological aspects of the Maillard browning reaction in foods.

Authors:  J O'Brien; P A Morrissey
Journal:  Crit Rev Food Sci Nutr       Date:  1989       Impact factor: 11.176

3.  Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.

Authors:  Evanthia Diamanti-Kandarakis; Ilias Katsikis; Christina Piperi; Krystallenia Alexandraki; Dimitrios Panidis
Journal:  Clin Endocrinol (Oxf)       Date:  2007-01       Impact factor: 3.478

Review 4.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Authors:  H Vlassara; R Bucala; L Striker
Journal:  Lab Invest       Date:  1994-02       Impact factor: 5.662

5.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

Authors:  Helen Vlassara; Weijing Cai; Jill Crandall; Teresia Goldberg; Robert Oberstein; Veronique Dardaine; Melpomeni Peppa; Elliot J Rayfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

6.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients.

Authors:  Jaime Uribarri; Melpomeni Peppa; Weijing Cai; Teresia Goldberg; Min Lu; Cijiang He; Helen Vlassara
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

7.  Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice.

Authors:  Reigh-Yi Lin; Ernane D Reis; Anthony T Dore; Min Lu; Newsha Ghodsi; John T Fallon; Edward A Fisher; Helen Vlassara
Journal:  Atherosclerosis       Date:  2002-08       Impact factor: 5.162

8.  Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.

Authors:  Feng Zheng; Cijiang He; Weijing Cai; Masakazu Hattori; Michael Steffes; Helen Vlassara
Journal:  Diabetes Metab Res Rev       Date:  2002 May-Jun       Impact factor: 4.876

9.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

Authors:  Susanna M Hofmann; Heng-Jiang Dong; Zhu Li; Weijing Cai; Jennifer Altomonte; Swan N Thung; Feng Zeng; Edward A Fisher; Helen Vlassara
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.

Authors:  D R McCance; D G Dyer; J A Dunn; K E Bailie; S R Thorpe; J W Baynes; T J Lyons
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  32 in total

1.  Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells.

Authors:  Eleni A Kandaraki; Antonios Chatzigeorgiou; Efstathia Papageorgiou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou; Michael Koutsilieris; Evanthia Diamanti-Kandarakis
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-15

2.  Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.

Authors:  Deepika Garg; Richard Grazi; Geralyn M Lambert-Messerlian; Zaher Merhi
Journal:  J Assist Reprod Genet       Date:  2017-08-19       Impact factor: 3.412

3.  The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

Authors:  Alexandra Bargiota; Evanthia Diamanti-Kandarakis
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

Review 4.  Systemic effects of AGEs in ER stress induction in vivo.

Authors:  Christos Adamopoulos; Chrysovalantou Mihailidou; Christofora Grivaki; Kostas A Papavassiliou; Hippokratis Kiaris; Christina Piperi; Athanasios G Papavassiliou
Journal:  Glycoconj J       Date:  2016-05-28       Impact factor: 2.916

5.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

Review 6.  Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging.

Authors:  Chandan Prasad; Victorine Imrhan; Francesco Marotta; Shanil Juma; Parakat Vijayagopal
Journal:  Aging Dis       Date:  2014-06-01       Impact factor: 6.745

7.  Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.

Authors:  P Gopal; H R Gosker; C C de Theije; I M Eurlings; D R Sell; V M Monnier; N L Reynaert
Journal:  Biochim Biophys Acta       Date:  2015-02-19

Review 8.  PCOS Forum: research in polycystic ovary syndrome today and tomorrow.

Authors:  Renato Pasquali; Elisabet Stener-Victorin; Bulent O Yildiz; Antoni J Duleba; Kathleen Hoeger; Helen Mason; Roy Homburg; Theresa Hickey; Steve Franks; Juha S Tapanainen; Adam Balen; David H Abbott; Evanthia Diamanti-Kandarakis; Richard S Legro
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

Review 9.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

Review 10.  The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome.

Authors:  E Kassi; E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.